In vitro synergism of antimutagenic and antioxidant activities of Phoenix dactylifera fruit

The availability of total phenolics of date flesh (Pheonix dactylifera) in aqueous and acidified methanol and in vitro synergism of their antimutagenic and antioxidant activities were investigated. The antimutagenic activities of date flesh extracts tested against Salmonella strains TA-98 and TA-100 using Ames bacterial testing were in the range of 36.47 to 79.74% against the standard mutagens potassium dichromate and sodium azide. The antioxidant activities assessed as maximal inhibitory concentrations (IC₅₀) for DPPH radicals and linoleic acid peroxidation inhibition were 812.90 to 2,076.10 μg/mL and 54.43 to 80.89%, respectively. The total phenolic contents of date flesh extracts (35.76 to 114.09mg/g of gallic acid equivalents) were found to be correlated with the biological activities. Use of 0.5 N acidified methanol was efficient for extraction of phenolic compounds with retained antioxidant and antimutagen activities. Dates are a good candidate as a source for development of chemotherapeutic drugs, nutracueticals, and functional food ingredients.     

Novel multiplex PCR-RFLP assay discriminates bovine,porcine and fish gelatin substitution in Asian pharmaceuticals capsule shells

Gelatin is widely used in pharmaceuticals as a protective coating, such as soft and hard capsule shells. However, the animal source of gelatin is a sensitive issue because certain gelatins such as porcine and bovine gelatins are not welcome in Halal, Kosher and Hindus’ consumer goods. Recently, we have documented DNA barcoding and multiplex PCR platforms for discriminating porcine, bovine and fish gelatins in various fish and confectionary products; but those assays were not self-authenticating and also not tested in highly refined pharmaceutical products. To address this knowledge gap, here we report a self-authenticating multiplex PCR-restriction fragment length polymorphism (RFLP) assay to identify animal sources of various gelatin in pharmaceutical capsules. Three different restriction enzymes, BsaAI, Hpy188I and BcoDI were used to yield distinctive RFLP patterns for gelatin-based bovine (26, 94 bp), fish (97, 198 bp) and porcine (17, 70 bp) DNA in control experiments. The specificity was cross-tested against 16 non-target species and the optimised assay was used to screen gelatin sources in 30 halal-branded pharmaceuticals capsule shells. Bovine and porcine DNA was found in 27 and 3 of the 30 different capsules products. The assay was suitable for detecting 0.1 to 0.01 ng total DNA extracted from pure and mixed gelatins. The study might be useful to authenticate and monitor halal, kosher, vegetarian and Hindu compliant pharmaceuticals, foods and cosmetics.     

High Resistance of Cu–Ferrierite to Coke Formation During NH3-SCR in the Presence of n-Decane

Selective catalytic reduction of NO _x by NH₃ over Cu–FER and Cu–ZSM-5 in the presence of n-decane and SO₂ was investigated. NO _x conversion over Cu–ZSM-5 decreased in the presence of n-decane, owing to inhibition of the active sites by coke formation. In contrast, coke formation was negligible over Cu–FER, which maintained its NO _x conversion activity even in the presence of decane. Coke formation was negligible over H–ZSM-5 and H–FER supports, which suggests that Cu species were involved in coke formation. Temperature-programmed reduction by H₂ and electron spin resonance spectroscopy indicated that [Cu–O–Cu]²⁺ was probably the Cu species involved in coke formation over Cu–ZSM-5.     

Taste masking technologies in oral pharmaceuticals: recent developments and approaches

Taste is one of the most important parameters governing patient compliance. Undesirable taste is one of several important formulation problems that are encountered with certain drugs. Oral administration of bitter drugs with an acceptable degree of palatability is a key issue for health care providers, especially for pediatric patients. Several oral pharmaceuticals, numerous food and beverage products, and bulking agents have unpleasant, bitter-tasting components. So, any pharmaceutical formulation with a pleasing taste would definitely be preferred over a competitor's product and would translate into better compliance and therapeutic value for the patient and more business and profits for the company. The desire of improved palatability in these products has prompted the development of numerous formulations with improved performance and acceptability. This article reviews the earlier applications and methodologies of taste masking and discusses the most recent developments and approaches of bitterness reduction and inhibition for oral pharmaceuticals.     

Effect of surface tension gradient on gas hold-up enhancement in aqueous solutions of electrolytes

The effect of addition of electrolytes on gas hold-up of air/water system was investigated experimentally in a laboratory scale bubble column. The experiments were carried out with four electrolytes, namely, NaCl, MgSO₄·7H₂O, Na₂SO₄ and CaCl₂·2H₂O and the concentrations of the solutions were varied from 0 to 0.3 mol/l. Enhancement of gas hold-up was observed for all four electrolytes at concentrations less than 0.1 mol/l. With the increase in concentration, the gas hold-up showed two different trends; in Na₂SO₄ and CaCl₂·2H₂O solutions, gas hold-up formed a sharp peak after the enhancement and leveled off at a value somewhat higher than that in water, whereas in NaCl and MgSO₄·7H₂O solutions, gas hold-up leveled off immediately after the enhancement without forming any peak. Experiments were also conducted to measure the surface tensions of the solutions with special focus in the low concentration region. A strong relation between the gas hold-up enhancement and the change of surface tension with the addition of electrolyte was found. It was also observed that the concentration at which maximum value of C(dσ/dC)² i.e. (concentration × surface tension gradient with respect to concentration²) is obtained corresponds to the concentration at which maximum gas hold-up enhancement occurs.     

Fabrication of 3D chitosan–hydroxyapatite scaffolds using a robotic dispensing system

A new robotic desktop rapid prototyping (RP) system was designed to fabricate scaffolds for tissue engineering applications. The experimental setup consists of a computer-guided desktop robot and a one-component pneumatic dispenser. The dispensing material (chitosan and chitosan–hydroxyapatite (HA) dissolved in acetic acid) was stored in a 30-ml barrel and forced out through a small Teflon-lined nozzle into a dispensing medium (sodium hydroxide–ethanol in ratio of 7:3). Layer-by-layer, the chitosan was fabricated with a preprogramed lay-down pattern. Neutralization of the chitosan forms a gel-like precipitate, and the hydrostatic pressure in the sodium hydroxide (NaOH) solution keeps the cuboid scaffold in shape. Comparison of the freeze-dried scaffold to the wet one showed linear and volumetric shrinkage of about 31% and 62%, respectively. A good attachment between layers allowed the chitosan matrix to form a fully interconnected channel architecture. Results of in vitro cell culture studies revealed the scaffold biocompatibility. The results of this preliminary study using the rapid prototyping robotic dispensing (RPBOD) system demonstrated its potential in fabricating three-dimensional (3D) scaffolds with regular and reproducible macropore architecture.     

Synthesis,Characterization and Evaluation of the Surface Active Properties of Novel Cationic Imidazolium Gemini Surfactants

New imidazolium gemini surfactants were synthesized by reaction of epichlorohydrin with long chain fatty alcohols furnishing products 2-(alkoxymethyl)oxirane followed by their subsequent treatment with imidazole resulting in the formation of 1-(1H-imidazol-1-yl-3 alkoxy)propane-2-ol which on subsequent treatment with 1,2-dibromoethane and 1,3-dibromopropane resulted in the formation of title gemini surfactants:1,2-bis(1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)ethane bromide (7), 1,3-bis(1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)propane bromide (8), 1,2-bis(1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)ethane bromide (9), 1,3-bis(1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)propane bromide (10), 1,2-bis (1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)ethane bromide (11) and 1,3-bis (1(3-alkoxy-2-hydroxypropyl)-1H-imidazol-3-ium)propane bromide (12). Their identification was based on IR, ¹H-, ¹³C-NMR, DEPT, COSY and mass spectral studies. Their surface active properties were also evaluated on the basis of surface tension and conductivity measurements.